Related Experiment Videos
[Percutaneous transthoracic aspiration biopsy guided by computer tomography]
F Dalagija1, S Beslić, Z Dizdarević
1Institut za radiologiju i onkologiju, UMC Sarajevo.
Plucne Bolesti : Casopis Udruzenja Pneumoftiziologa Jugoslavije = the Journal of Yugoslav Association of Phthisiology and Pneumology
|July 1, 1990
Summary
CT-guided transthoracic needle biopsy is a valuable interventional radiology procedure for diagnosing cancer. This study found it to be cytologically representative in most cases, with pneumothorax and hematoma as the most common complications.
Area of Science:
- Radiology
- Interventional Radiology
- Oncology
Background:
- Percutaneous transthoracic aspiration biopsy is a key interventional radiology procedure.
- It is frequently employed for the diagnosis and staging of malignant neoplastic processes.
- Computed tomography (CT) offers advantages over fluoroscopy for needle visualization and accessing small lesions.
Purpose of the Study:
- To evaluate the efficacy and safety of CT-guided Chiba needle percutaneous transthoracic aspiration biopsy.
- To determine the cytological representativeness of samples obtained via this method.
- To identify and analyze the incidence of complications associated with the procedure.
Main Methods:
- Retrospective analysis of 195 patient cases undergoing CT-guided Chiba needle percutaneous transthoracic aspiration biopsy.
- Evaluation of sample adequacy for cytologic analysis.
- Documentation and assessment of procedural complications.
Main Results:
- The procedure yielded cytologically representative findings in 85.64% of cases.
- Unrepresentative findings occurred in 14.36% of cases.
- The most frequent complications were pneumothorax (9.74%) and perifocal hematoma (9.23%).
Conclusions:
- CT-guided percutaneous transthoracic aspiration biopsy is an effective method for obtaining cytologically representative samples.
- The procedure is associated with a low rate of significant complications.
- This technique is a valuable tool for definitive diagnosis and therapeutic planning in oncology.